Ionis Pharmaceuticals to share business, pipeline progress at Innovation Day

Ionis Pharmaceuticals is holding an investor and analyst event, Ionis Innovation Day: Discovering, Developing and Delivering Transformational Medicines, in New York City today. Presentations from Ionis leaders and external physicians will highlight Ionis’ comprehensive integrated research, development, and commercialization capabilities, along with key pipeline and technology highlights. With experienced commercial team in place, Ionis is poised to independently bring steady cadence of potentially transformational RNA-targeted medicines to patients beginning in 2024. It plans to add four new wholly owned neurology medicines to its clinical pipeline by end of 2024. Innovative technology advances will unlock new opportunities in neurology and cardiology as well as in new therapeutic areas. With multiple launches anticipated over the coming years, Ionis is positioned for next-level value creation driven by significant revenue growth and positive cash flow.